These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6680533)

  • 21. [Analysis of clinical state for arteriosclerosis obliterans in lower extremity of diabetic patients on peritoneal dialysis].
    Shi JB; Sun QH; Nie JD; Sun LH; Zhang N; Han QF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Feb; 45(1):109-13. PubMed ID: 23411531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes.
    Beach KW; Strandness DE
    Diabetes; 1980 Nov; 29(11):882-8. PubMed ID: 7429028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intestinal arteriosclerosis. Pathomorphological findings, localization and occurrence].
    Zahn DG; Goerttler K
    Arch Kreislaufforsch; 1971; 64(3):235-72. PubMed ID: 5088420
    [No Abstract]   [Full Text] [Related]  

  • 24. [Role of several risk factors in chronic obliterating arteriopathies of the extremities].
    Stăncioiu N
    Med Interna (Bucur); 1971 Dec; 23(12):1415-26. PubMed ID: 5159278
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans.
    Liu Y; Cui Y; Zhou Z; Liu B; Liu Z; Li G
    Dis Markers; 2023; 2023():1316821. PubMed ID: 36865500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between arteriosclerosis obliterans and the ratio of serum eicosapentaenoic acid to arachidonic acid.
    Fukuda S; Fujioka S; Hosaka S; Akita S; Kimura S; Kurotani K; Mizoue T
    Ann Thorac Cardiovasc Surg; 2014; 20(1):44-7. PubMed ID: 23364231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etiologic considerations in peripheral vascular diseases of the lower extremity with special reference to diabetes mellitus.
    Blumenthal HT; Berns AW; Goldenberg S; Lowenstein PW
    Circulation; 1966 Jan; 33(1):98-106. PubMed ID: 5322602
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diabetes mellitus and arteriosclerosis].
    Kunz O
    Med Monatsschr; 1971 Jul; 25(7):308-12. PubMed ID: 4935350
    [No Abstract]   [Full Text] [Related]  

  • 29. Arteriosclerosis obliterans in young women.
    Holmes DR; Burbank MK; Fulton RE; Bernatz PE
    Am J Med; 1979 Jun; 66(6):997-1000. PubMed ID: 453230
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of gangrene in patients with diabetes mellitus].
    Tkach FS; Volodos' NL; Voropaĭ TI
    Vestn Khir Im I I Grek; 1987 Jul; 139(7):136-9. PubMed ID: 3424543
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hyperlipidemia and arteriosclerosis obliterans].
    Shindo S
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():690-7. PubMed ID: 11351672
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lumbar sympathectomy in patients with arteriosclerosis obliterans of the lower extremities and diabetes mellitus].
    Kokhan EP; Batrashov VA; Mitroshin GE; Kokhan VE
    Klin Khir (1962); 1990; (7):69. PubMed ID: 2232548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life improvement and long-term effects of peripheral blood mononuclear cell transplantation for severe arteriosclerosis obliterans in diabetic patients on dialysis.
    Hoshino J; Ubara Y; Hara S; Sogawa Y; Suwabe T; Higa Y; Nakanishi S; Sawa N; Katori H; Takemoto F; Fujimoto Y; Ohta E; Ohara K; Takaichi K
    Circ J; 2007 Aug; 71(8):1193-8. PubMed ID: 17652880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cerebrovascular diseases in patients with arteriosclerotic aortic aneurysm and arteriosclerosis obliterans studied by carotid ultrasonography and by computed tomography of the brain].
    Iwamoto T; Sugiyama T; Oyama T; Takasaki M
    Nihon Ronen Igakkai Zasshi; 1998 Sep; 35(9):673-9. PubMed ID: 9865061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Principles of conservative therapy of chronic arterial circulatory disorders].
    Heidrich H
    Internist (Berl); 1971 Sep; 12(9):377-85. PubMed ID: 4938931
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum lipids and lipoproteins in arteriosclerosis obliterans of the lower extremities.
    Berezovsky LA; de Wolfe VG; Lewis LA
    Medicina (B Aires); 1978; 38(6 Pt 1):652-8. PubMed ID: 750857
    [No Abstract]   [Full Text] [Related]  

  • 37. [Correlation of arteriosclerosis obliterans of the lower extremity with coronary artery disease].
    Hamai K; Hiasa Y; Wada T; Morimoto S; Aihara T; Kataoka Y; Mori H
    J Cardiol; 1989 Mar; 19(1):103-12. PubMed ID: 2810031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved skin blood flow and cutaneous temperature in the foot of a patient with arteriosclerosis obliterans by vasopressin V1 antagonist (OPC21268). A case report.
    Toba K; Ouchi Y; Akishita M; Kozaki K; Ishikawa M; Nagano K; Etoh M; Hashimoto M; Liang J; Ueda N
    Angiology; 1995 Nov; 46(11):1027-33. PubMed ID: 7486224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The significance of morphological comparative investigations on the arteriosclerotic and diabetic arteries for practical proceeding for the physician and nurse (author's transl)].
    Panecka A; Buczyński E; Stepień A; Szczygielska M
    Ann Univ Mariae Curie Sklodowska Med; 1979; 34():93-7. PubMed ID: 262158
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
    Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
    ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.